aliskiren and Macular-Degeneration

aliskiren has been researched along with Macular-Degeneration* in 1 studies

Other Studies

1 other study(ies) available for aliskiren and Macular-Degeneration

Article	Year
New drug update: 2007. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2008, Volume: 23, Issue:4 A unique rating system compares five new drugs with existing therapies and evaluates the uses and most important properties of each new agent. Advantages, disadvantages, and other important information regarding the new drug are considered and identified, including their use in the elderly. Topics: Aged; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Antiparkinson Agents; Antipsychotic Agents; Drug Approval; Fumarates; Humans; Hypoglycemic Agents; Isoxazoles; Macular Degeneration; Paliperidone Palmitate; Pyrazines; Pyrimidines; Ranibizumab; Sitagliptin Phosphate; Tetrahydronaphthalenes; Thiophenes; Triazoles; United States	2008

Article

Year

New drug update: 2007.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2008, Volume: 23, Issue:4

A unique rating system compares five new drugs with existing therapies and evaluates the uses and most important properties of each new agent. Advantages, disadvantages, and other important information regarding the new drug are considered and identified, including their use in the elderly.

Topics: Aged; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Antiparkinson Agents; Antipsychotic Agents; Drug Approval; Fumarates; Humans; Hypoglycemic Agents; Isoxazoles; Macular Degeneration; Paliperidone Palmitate; Pyrazines; Pyrimidines; Ranibizumab; Sitagliptin Phosphate; Tetrahydronaphthalenes; Thiophenes; Triazoles; United States

2008